The center for Bone Marrow Transplantation (BMT Center) at Seoul St. Mary’s hospital accomplishes more than 7,000 BMT cases following the Korea’s first successful hematopoietic stem cell transplantation in 1983. Patients using Seoul St. Mary’s hospital’s BMT have had 10~30% higher survival rate than others in US hospitals. The BMT center has treated patients with divisions of hematology, infectious diseases, pediatrics, pulmonology, and radiology.
Since the successful surgery of stem cell transplantation between sisters from Abu Dhabi, the capital of the UAE, in 2012, the number of international patients with hematopoietic stem cell transplantation continue to rise sharply; 4 in 2012, 13 in 2013, 24 in 2014, and 26 in 2015. The hospital has provided personalized treatment, according to patient’s condition, age, and risk factors of highly complex and diverse hematological cancer. Meanwhile, the BMT center is leading the global clinical trial. Patients from advanced countries in medicine, such as the United States, to Russia, Mongolia, Kazakhstan, the United Arab Emirates and Egypt have visited the centers and are still waiting for transplants.